TERT and melanoma: In accordance, we found in our cohort of BRAF-mutated patients that most melanomas (85%) presented a mutation in the TERT promoter, the most frequent being −124C > T (50%) followed by −146C > T (28%) and by −138/−139CC > TT (7%).